Combining cannabidiol (CBD) with a benzodiazepine can increase sedation, raising concern for falls and injuries in someone with dementia. The clearest measured drug interaction involves clobazam, but other benzodiazepines can still add to CBD's brain-slowing effects. The FDA warns in its consumer guidance on CBD that combining CBD with medicines for anxiety or sleep can increase drowsiness and injury risk. This does not mean every combination will cause a fall, but it warrants a medication review.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why dementia makes sedation more consequential
- What kind of interaction can occur?
- How well does the evidence apply to dementia?
- What should caregivers review before combining them?
Why dementia makes sedation more consequential
People with dementia may already be vulnerable to confusion and falls. For people living with Alzheimer's disease, the National Institute on Aging's treatment guidance says benzodiazepines can cause sleepiness, dizziness, falls, and confusion. It recommends them only for short periods, if at all.
The National Institute on Aging also identifies mild cognitive impairment and certain dementias as fall-risk conditions. Adding cbd may compound problems that are already present rather than create an entirely new symptom. Watch for a noticeable change after CBD is started or increased. New sleepiness, dizziness, confusion, or falls should prompt a medication review instead of being assumed to reflect dementia progression.
What kind of interaction can occur?
Two issues matter. The first is additive impairment: CBD and a benzodiazepine can both contribute to sedation even when no change in blood concentration has been measured. The second is a pharmacokinetic interaction, meaning one drug changes how the body processes another. In controlled trials summarized in the FDA's June 2025 Epidiolex prescribing information, somnolence or sedation occurred in 32% of CBD-treated patients and 11% of placebo patients. Among CBD-treated patients, the rates were 46% with clobazam and 16% without it.
Clobazam has the strongest documented drug-specific evidence. FDA clobazam prescribing information states that CBD produced a threefold increase in N-desmethylclobazam, clobazam's active metabolite. That increase can raise the likelihood of clobazam-related adverse effects. Equivalent interaction numbers are not available for every benzodiazepine. The appropriate conclusion is not that all benzodiazepines triple in concentration, but that additive sedation remains possible across the class.
How well does the evidence apply to dementia?
The strongest quantified evidence is not dementia-specific. The FDA Epidiolex label reports that pivotal CBD seizure trials had a mean participant age of 14 and included too few people older than 55 to determine whether their responses differed. Those trials establish a sedation signal and a specific clobazam interaction.
They cannot predict the exact risk for an older person with dementia, existing balance problems, or several sedating medicines. The FDA has approved only Epidiolex for specified seizure disorders, not dementia. Unapproved CBD products may contain inaccurate amounts of CBD, contaminants, or ingredients with unevaluated interactions. Results from a standardized prescription product may therefore not translate neatly to another CBD product.
What should caregivers review before combining them?
Ask the prescriber or pharmacist to review the exact CBD product alongside the complete medication list. Include: If the person already uses both, look for changes from their usual alertness and mobility.
A product label is helpful for the review, but it may not confirm the CBD amount in an unapproved product. Contact the care team promptly about worsening sedation, confusion, dizziness, or balance. Seek urgent help after a serious fall or injury, or if the person is unusually difficult to wake, and get clinical instructions before changing a prescribed medicine.
- The specific benzodiazepine, dose, schedule, and reason for use
- The CBD product, labeled amount, dose, timing, and frequency
- Prescription medicines, nonprescription medicines, and supplements
- Recent changes in sleepiness, dizziness, confusion, walking, or falls
- Whether CBD or the benzodiazepine was recently started or increased
